Literature DB >> 16847087

Insights into the interaction between influenza virus and pneumococcus.

Jonathan A McCullers1.   

Abstract

Bacterial infections following influenza are an important cause of morbidity and mortality worldwide. Based on the historical importance of pneumonia as a cause of death during pandemic influenza, the increasingly likely possibility that highly pathogenic avian influenza viruses will trigger the next worldwide pandemic underscores the need to understand the multiple mechanisms underlying the interaction between influenza virus and bacterial pathogens such as Streptococcus pneumoniae. There is ample evidence to support the historical view that influenza virus alters the lungs in a way that predisposes to adherence, invasion, and induction of disease by pneumococcus. Access to receptors is a key factor and may be facilitated by the virus through epithelial damage, by exposure or up-regulation of receptors, or by provoking the epithelial regeneration response to cytotoxic damage. More recent data indicate that alteration of the immune response by diminishing the ability of the host to clear pneumococcus or by amplification of the inflammatory cascade is another key factor. Identification and exploration of the underlying mechanisms responsible for this synergism will provide targets for prevention and treatment using drugs and vaccines.

Entities:  

Mesh:

Year:  2006        PMID: 16847087      PMCID: PMC1539103          DOI: 10.1128/CMR.00058-05

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  144 in total

Review 1.  PAf receptor anchors Streptococcus pneumoniae to activated human endothelial cells.

Authors:  D R Cundell; C Gerard; I Idanpaan-Heikkila; E I Tuomanen; N P Gerard
Journal:  Adv Exp Med Biol       Date:  1996       Impact factor: 2.622

2.  Impact of influenza vaccination on seasonal mortality in the US elderly population.

Authors:  Lone Simonsen; Thomas A Reichert; Cecile Viboud; William C Blackwelder; Robert J Taylor; Mark A Miller
Journal:  Arch Intern Med       Date:  2005-02-14

Review 3.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

4.  Interleukin-10 impairs host defense in murine pneumococcal pneumonia.

Authors:  T van der Poll; A Marchant; C V Keogh; M Goldman; S F Lowry
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

Review 5.  Cellular and molecular mechanisms of bacterial adhesion to respiratory mucosa.

Authors:  M C Plotkowski; O Bajolet-Laudinat; E Puchelle
Journal:  Eur Respir J       Date:  1993-06       Impact factor: 16.671

6.  Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae.

Authors:  Jonathan A McCullers; Kimberly C Bartmess
Journal:  J Infect Dis       Date:  2003-03-06       Impact factor: 5.226

7.  Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus.

Authors:  Loïc Guillot; Ronan Le Goffic; Sarah Bloch; Nicolas Escriou; Shizuo Akira; Michel Chignard; Mustapha Si-Tahar
Journal:  J Biol Chem       Date:  2004-12-03       Impact factor: 5.157

8.  Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza.

Authors:  Jonathan A McCullers
Journal:  J Infect Dis       Date:  2004-06-30       Impact factor: 5.226

9.  Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice.

Authors:  Judith Branger; Sylvia Knapp; Sebastiaan Weijer; Jaklien C Leemans; Jennie M Pater; Peter Speelman; Sandrine Florquin; Tom van der Poll
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

10.  Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection.

Authors:  Richard Malley; Philipp Henneke; Sarah C Morse; Michael J Cieslewicz; Marc Lipsitch; Claudette M Thompson; Evelyn Kurt-Jones; James C Paton; Michael R Wessels; Douglas T Golenbock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-04       Impact factor: 11.205

View more
  359 in total

Review 1.  Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens.

Authors:  Vincent A Fischetti
Journal:  Int J Med Microbiol       Date:  2010-05-10       Impact factor: 3.473

2.  Immunopathogenic and antibacterial effects of H3N2 influenza A virus PB1-F2 map to amino acid residues 62, 75, 79, and 82.

Authors:  Irina V Alymova; Amanda M Green; Nicholas van de Velde; Julie L McAuley; Kelli L Boyd; Hazem E Ghoneim; Jonathan A McCullers
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

3.  Influenza virus induces bacterial and nonbacterial otitis media.

Authors:  Kirsty R Short; Dimitri A Diavatopoulos; Ruth Thornton; John Pedersen; Richard A Strugnell; Andrew K Wise; Patrick C Reading; Odilia L Wijburg
Journal:  J Infect Dis       Date:  2011-09-19       Impact factor: 5.226

4.  Influenza virus primes mice for pneumonia from Staphylococcus aureus.

Authors:  Amy R Iverson; Kelli L Boyd; Julie L McAuley; Lisa R Plano; Mark E Hart; Jonathan A McCullers
Journal:  J Infect Dis       Date:  2011-01-28       Impact factor: 5.226

5.  Statins and influenza: can we move forward?

Authors:  Edward E Walsh
Journal:  J Infect Dis       Date:  2011-12-13       Impact factor: 5.226

6.  Unveiling the burden of influenza-associated pneumococcal pneumonia.

Authors:  Carlos G Grijalva; Marie R Griffin
Journal:  J Infect Dis       Date:  2011-12-07       Impact factor: 5.226

Review 7.  Influenza-related pneumonia.

Authors:  Mark H Almond; Danny F McAuley; Matt P Wise; Mark J D Griffiths
Journal:  Clin Med (Lond)       Date:  2012-02       Impact factor: 2.659

8.  1918 pandemic influenza virus and Streptococcus pneumoniae co-infection results in activation of coagulation and widespread pulmonary thrombosis in mice and humans.

Authors:  Kathie-Anne Walters; Felice D'Agnillo; Zong-Mei Sheng; Jason Kindrachuk; Louis M Schwartzman; Rolf E Kuestner; Daniel S Chertow; Basil T Golding; Jeffery K Taubenberger; John C Kash
Journal:  J Pathol       Date:  2015-10-14       Impact factor: 7.996

Review 9.  Pathology of human influenza revisited.

Authors:  Thijs Kuiken; Jeffery K Taubenberger
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

10.  Regulation of IFN-γ by IL-13 dictates susceptibility to secondary postinfluenza MRSA pneumonia.

Authors:  Agnieszka Rynda-Apple; Ann Harmsen; Anfin S Erickson; Kyle Larson; Rachelle V Morton; Laura E Richert; Allen G Harmsen
Journal:  Eur J Immunol       Date:  2014-09-01       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.